Clinical Trial Update: Reversal to Normoglycemia by Treating Prediabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is investigating reversing to normoglycemia by treating prediabetes; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Prediabetes

Snippet

Sponsor: Michael Mæng | Conditions: Prediabetes, Chronic Coronary Syndrome | Phase 3 | Status: NOT_YET_RECRUITING